January 29, 2007
Genentech Drug Lucentis Linked to Strokes in Elderly
Posted at January 29, 2007 5:29 PM in .
Genentech Inc. has issued a warning to eye specialists that its drug Lucentis has been found to increase the risk of strokes in patients taking the drug for age-relate blindness. Lucentis, manufactured by Genentech, has been prescribed for age-related macular degeneraton, a condition affecting approximately 1.4 million Americans. Lucentis had been marketed as specifically for eye treatment and safer than its parent compound Avastin.
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/352 .